Article thumbnail

Effectiveness and safety of outpatient pleurodesis in patients with recurrent malignant pleural effusion and low performance status

By Ricardo Mingarini Terra, Lisete Ribeiro Teixeira, Benoit Jacques Bibas, Paulo Manuel Pego‐Fernandes, Francisco Suso Vargas and Fabio Biscegli Jatene
Topics: Clinical Science
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier: oai:pubmedcentral.nih.gov:3059870
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Efficacy and safety of iodopovidone pleurodesis in malignant pleural effusions.
  2. (2008). Efficacy of iodopovidone pleurodesis and comparison of small-bore catheter versus large-bore chest tube. Ann Surg Oncol.
  3. Identification of clinical factors predicting Pleur(x)((R)) catheter removal in patients treated for malignant pleural effusion.
  4. (1998). Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration.
  5. Malignant pleural effusions: management options with consideration of coding, billing, and a decision approach.
  6. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter.
  7. Pe ˆgo-Fernandes PM, Jatene FB. Is Full Postpleurodesis Lung Expansion a Determinant of a Successful Outcome After Talc Pleurodesis?
  8. Pleural drainage and pleurodesis: implementation of guidelines in four hospitals.
  9. (2004). Pleurodesis for malignant pleural effusions (Cochrane Review). In: The Cochrane Library,
  10. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
  11. Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions.
  12. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
  13. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion.
  14. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
  15. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
  16. (1996). Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg.
  17. Thoracoscopy talc poudrage: a 15-year experience.
  18. Use of tunneled catheters for malignant pleural effusions in patients fit for pleurodesis.
  19. (2007). Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg.